BRD2 and neoplasm: Post-treatment, fibroblasts activated the proliferation pathway of epithelial cells through focal adhesions, specifically the PI3K-AKT signaling pathway, which may be a key mechanism underlying tumor cell resistance to NAT (Figures 4E,F).